LifeMD (LFMD) Debt/Equity Ratio: History & Chart

LifeMD, Inc.(LFMD)

Medical - Healthcare Information Services · New York City, NY

$2.79+0.06 (+2.39%)

Delayed quote: Oct 6, 2026, 10:24 AM EDT

About LifeMD, Inc.

LifeMD, Inc. operates as a leading digital health company, specializing in direct-to-consumer telemedicine across the United States. The firm links individuals with licensed medical professionals to address a diverse spectrum of health concerns, including concierge services, men's sexual health, dermatological conditions, and more. Under its umbrella, LifeMD manages several specialized virtual care platforms: ShapiroMD is a telehealth brand focused on hair restoration, delivering virtual consultations, prescription medications, patented over-the-counter formulations, an FDA-cleared medical device, and custom-compounded topical treatments for both male and female hair loss. RexMD serves as a men's telehealth brand, providing virtual medical treatment from licensed providers for a wide array of male-specific health needs. LifeMD Primary Care offers a personalized, subscription-based virtual primary care solution, addressing routine, urgent, and chronic health management requirements. This mobile-centric platform integrates remote consultations, medication management, diagnostic services, and imaging referrals. Cleared is a telehealth service dedicated to offering personalized therapies for allergic, asthmatic, and immunological conditions. Nava MD stands as a skincare and tele-dermatology brand catering specifically to women, facilitating virtual access to dermatologists and other specialists for medical treatment. Additionally, the company provides PDFSimpli, a cloud-based software-as-a-service (SaaS) platform that empowers users to create, edit, convert, sign, and share PDF documents online. LifeMD distributes its offerings directly to individuals, via its own e-commerce channels, and through collaborations with external partners. Originally established in 1994 as Conversion Labs, Inc., the company rebranded to LifeMD, Inc. in February 2021 and is headquartered in New York City.

New York City, NY

350 employees

www.lifemd.com

Healthcare / Medical - Healthcare Information Services

Sector: Healthcare
Industry: Medical - Healthcare Information Services
CEO: Justin Schreiber

View full financials

LFMD Debt to Equity Ratio Metrics

DEBT TO EQUITY RATIO

0.76

DEBT TO EQUITY RATIO AVG TTM

-1.19

DEBT TO EQUITY RATIO AVG 3Y

-2.26

DEBT TO EQUITY RATIO AVG 5Y

-0.56

DEBT TO EQUITY RATIO AVG 10Y

-0.34

DEBT TO EQUITY RATIO AVG 15Y

-0.10

DEBT TO EQUITY RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

+163.28%

CURRENT VS 3Y AVG

+133.43%

CURRENT VS 5Y AVG

+235.31%

CURRENT VS 10Y AVG

+323.94%

CURRENT VS 15Y AVG

+867.29%

CURRENT VS 20Y AVG

N/A

SECTOR MEDIAN · HEALTHCARE

0.13

median of 530 covered companies

CURRENT VS SECTOR MEDIAN

+481.01%

vs the sector median at left

NAME	MARKET CAP	DEBT TO EQUITY RATIO	TTM	3Y	5Y
LifeMD, Inc. (LFMD)	$134.69M	0.76	-1.19	-2.26	-0.56
Freenome, Inc. (FRNM)vs ›	$134.35M	N/A	N/A	N/A	N/A
Fortress Biotech, Inc. (FBIOP)vs ›	$137.77M	0.39	2.42	2.91	2.20
AirSculpt Technologies, Inc. (AIRS)vs ›	$138.27M	0.67	1.14	1.25	1.10
Health Catalyst, Inc. (HCAT)vs ›	$129.68M	1.69	0.90	0.77	0.69
Alpha Cognition Inc (ACOG)vs ›	$139.94M	0.00	0.01	0.01	50.25
KORU Medical Systems, Inc. (KRMD)vs ›	$140.05M	0.18	0.22	0.21	0.14
LifeMD, Inc. (LFMDP)vs ›	$142.72M	0.76	0.27	2.83	1.63
Entera Bio Ltd. (ENTX)vs ›	$124.95M	0.06	0.04	0.03	0.03
Immuneering Corporation (IMRX)vs ›	$144.48M	0.02	0.06	0.05	0.05

NAME

MARKET CAP

DEBT TO EQUITY RATIO

TTM

LifeMD, Inc. (LFMD)

$134.69M

0.76

-1.19

-2.26

-0.56

Freenome, Inc. (FRNM)vs ›

$134.35M

N/A

Fortress Biotech, Inc. (FBIOP)vs ›

$137.77M

0.39

2.42

2.91

2.20

AirSculpt Technologies, Inc. (AIRS)vs ›

$138.27M

0.67

1.14

1.25

1.10

Health Catalyst, Inc. (HCAT)vs ›

$129.68M

1.69

0.90

0.77

0.69

Alpha Cognition Inc (ACOG)vs ›

$139.94M

0.00

0.01

50.25

KORU Medical Systems, Inc. (KRMD)vs ›

$140.05M

0.18

0.22

0.21

0.14

LifeMD, Inc. (LFMDP)vs ›

$142.72M

0.76

0.27

2.83

1.63

Entera Bio Ltd. (ENTX)vs ›

$124.95M

0.06

0.04

0.03

Immuneering Corporation (IMRX)vs ›

$144.48M

0.02

0.06

0.05

Debt to Equity Ratio FAQ

What is the debt to equity ratio for LifeMD, Inc. (LFMD)?

The debt to equity ratio for LFMD stock is 0.76.

Is LifeMD, Inc.'s debt to equity ratio high or low?

The debt to equity ratio of 0.76 is 235% above its 5-year average of -0.56, near the high end of its 5-year range (-23.55–5.40).

What is the TTM average debt to equity ratio for LifeMD, Inc. (LFMD)?

The TTM average debt to equity ratio for LFMD stock is -1.19.

What is the 3Y average debt to equity ratio for LifeMD, Inc. (LFMD)?

The 3Y average debt to equity ratio for LFMD stock is -2.26.

What is the 5Y average debt to equity ratio for LifeMD, Inc. (LFMD)?

The 5Y average debt to equity ratio for LFMD stock is -0.56.

What is the 10Y average debt to equity ratio for LifeMD, Inc. (LFMD)?

The 10Y average debt to equity ratio for LFMD stock is -0.34.

What is the 15Y average debt to equity ratio for LifeMD, Inc. (LFMD)?

The 15Y average debt to equity ratio for LFMD stock is -0.10.

DATE	DEBT TO EQUITY RATIO
2026-06-30	0.76
2026-03-31	0.41
2025-12-31	0.27
2025-09-30	4.96
2025-06-30	-12.37
2025-03-31	-10.78
2024-12-31	-4.58
2024-09-30	-3.26
2024-06-30	-4.95
2024-03-31	-23.55
2023-12-31	5.40
2023-09-30	-1.59
2023-06-30	-1.39
2023-03-31	-2.25
2022-12-31	-0.60
2022-09-30	0.36
2022-06-30	0.20
2022-03-31	0.10
2021-12-31	0.07
2021-09-30	-0.82
2021-06-30	-3.15
2021-03-31	0.25
2020-12-31	0.79
2020-09-30	-0.24
2020-06-30	-0.25
2020-03-31	-0.19
2019-12-31	-0.85
2019-09-30	-1.60
2019-06-30	-0.20
2019-03-31	1.14
2018-12-31	0.28
2018-09-30	0.00
2018-06-30	0.05
2018-03-31	0.00
2017-12-31	0.19
2017-09-30	0.09
2017-06-30	-0.50
2017-03-31	-0.02
2016-12-31	-0.58
2016-09-30	0.71
2016-06-30	0.36
2016-03-31	1.30
2015-12-31	1.00
2015-09-30	-0.78
2015-06-30	-0.59
2015-03-31	-0.68
2014-12-31	-0.19
2014-09-30	-2.21
2014-06-30	1.60
2014-03-31	0.34
2013-12-31	0.21
2013-09-30	0.25
2013-06-30	0.00
2013-03-31	0.00
2012-12-31	0.00
2012-09-30	0.00
2012-06-30	0.00
2012-03-31	0.00

DATE

DEBT TO EQUITY RATIO

2026-06-30

0.76

2026-03-31

0.41

2025-12-31

0.27

2025-09-30

4.96

2025-06-30

-12.37

2025-03-31

-10.78

2024-12-31

-4.58

2024-09-30

-3.26

2024-06-30

-4.95

2024-03-31

-23.55

2023-12-31

5.40

2023-09-30

-1.59

2023-06-30

-1.39

2023-03-31

-2.25

2022-12-31

-0.60

2022-09-30

0.36

2022-06-30

0.20

2022-03-31

0.10

2021-12-31

0.07

2021-09-30

-0.82

2021-06-30

-3.15

2021-03-31

0.25

2020-12-31

0.79

2020-09-30

-0.24

2020-06-30

-0.25

2020-03-31

-0.19

2019-12-31

-0.85

2019-09-30

-1.60

2019-06-30

-0.20

2019-03-31

1.14

2018-12-31

0.28

2018-09-30

0.00

2018-06-30

0.05

2018-03-31

0.00

2017-12-31

0.19

2017-09-30

0.09

2017-06-30

-0.50

2017-03-31

-0.02

2016-12-31

-0.58

2016-09-30

0.71

2016-06-30

0.36

2016-03-31

1.30

2015-12-31

1.00

2015-09-30

-0.78

2015-06-30

-0.59

2015-03-31

-0.68

2014-12-31

-0.19

2014-09-30

-2.21

2014-06-30

1.60

2014-03-31

0.34

2013-12-31

0.21

2013-09-30

0.25

2013-06-30

0.00

2013-03-31

0.00

2012-12-31

0.00

2012-09-30

0.00

2012-06-30

0.00

2012-03-31

0.00

Debt to Equity Ratio: 0.76

LFMD Debt to Equity Ratio

LFMD Average Debt to Equity Ratio Chart

LFMD Current vs Average Debt to Equity Ratio Chart

LFMD Debt to Equity Ratio Metrics

LFMD Competitors' Debt to Equity Ratio

Financial Health

Debt to Equity Ratio Formula & Definition

Debt to Equity Ratio FAQ

LFMD Debt to Equity Ratio History

Related Metrics